Generation Bio Cash Flow from Investing Activities 2020-2023 | GBIO
Generation Bio cash flow from investing activities from 2020 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Generation Bio Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $-10 |
| 2022 | $-193 |
| 2021 | $193 |
| 2020 | $-205 |
| 2019 | $48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.199B | $0.006B |
| Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $18.218B | 6.35 |
| Dr Reddy's Laboratories (RDY) | India | $11.543B | 17.16 |
| Aspen Pharmacare (APNHY) | South Africa | $5.511B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $5.445B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $2.524B | 1.92 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.030B | 12.41 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.592B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.438B | 0.00 |
| Personalis (PSNL) | United States | $0.082B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.074B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.026B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.019B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |